Cite
Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-Infected Patients
MLA
Shelton, Mark J., et al. “Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-Infected Patients.” Antimicrobial Agents and Chemotherapy, vol. 47, no. 5, May 2003, pp. 1694–99. EBSCOhost, https://doi.org/10.1128/AAC.47.5.1694-1699.2003.
APA
Shelton, M. J., Hewitt, R. G., Adams, J., Della-Coletta, A., Cox, S., & Morse, G. D. (2003). Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-Infected Patients. Antimicrobial Agents and Chemotherapy, 47(5), 1694–1699. https://doi.org/10.1128/AAC.47.5.1694-1699.2003
Chicago
Shelton, Mark J., Ross G. Hewitt, John Adams, Andrew Della-Coletta, Steven Cox, and Gene D. Morse. 2003. “Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-Infected Patients.” Antimicrobial Agents and Chemotherapy 47 (5): 1694–99. doi:10.1128/AAC.47.5.1694-1699.2003.